INS and type 2 diabetes mellitus: In the present study, UroA significantly enhanced GU by L6 myotubes in the insulin absence and oral administration of UroA to KK-Ay/Ta mice, a mouse model of T2D exhibiting insulin resistance [35,36], and suppressed blood glucose elevation in IPGTT.